Loading…
Immix Biopharma, Inc. is projected to rise to $14.17 by 2027, a +62% move from its current price of $8.73. IMMX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $8.42 | $8.74 | $9.07 | +0.09% |
| May 30 | $8.30 | $8.75 | $9.21 | +0.18% |
| May 31 | $8.21 | $8.75 | $9.33 | +0.28% |
| Jun 1 | $8.14 | $8.76 | $9.43 | +0.37% |
| Jun 2 | $8.08 | $8.77 | $9.52 | +0.46% |
| Jun 3 | $8.02 | $8.78 | $9.61 | +0.56% |
| Jun 4 | $7.97 | $8.79 | $9.68 | +0.65% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.97 | $8.79 | $9.68 | +0.65% |
| Week 2 | $7.71 | $8.84 | $10.15 | +1.30% |
| Week 3 | $7.52 | $8.90 | $10.53 | +1.96% |
| Week 4 | $7.38 | $8.96 | $10.88 | +2.62% |
| Week 5 | $7.25 | $9.02 | $11.21 | +3.29% |
| Week 6 | $7.15 | $9.08 | $11.52 | +3.96% |
| Week 7 | $7.06 | $9.13 | $11.81 | +4.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Immix Biopharma, Inc. is a healthcare company that operates as a clinical-stage biopharmaceutical company. It engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.
Its lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc. was incorporated in 2012 and is headquartered in Los Angeles, California.
Immix Biopharma, Inc. (IMMX) is a healthcare stock with a current price of $8.78. It has a market cap of $625.05M and is ranked 2870. The stock trades within a technical framework that suggests a near-term setup with a bullish long-term outlook based on the multi-year forecast.
The 50-day moving average sits at $9.46 while the 200-day moving average is $5.73, providing context for recent price action. A key near-term support is at $8.60 and resistance at $10.66, with the 30-day trading range between $6.79 and $11.35.
A major floor 47.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.5% away) — a key level to hold.
The nearest ceiling, 22.1% above — a clean break opens room to run.
A major ceiling 30.5% above — clearing it would confirm fresh momentum.
Key IMMX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IMMX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $8.79 | Sell | $8.86 | Sell |
| MA 10 | $9.23 | Sell | $9.09 | Sell |
| MA 20 | $9.42 | Sell | $9.30 | Sell |
| MA 50 | $9.39 | Sell | $9.15 | Sell |
| MA 100 | $8.17 | Buy | $8.21 | Buy |
| MA 200 | $5.79 | Buy | $6.60 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.32 | Neutral |
| Stoch RSI (14) | 5.21 | Buy |
| CCI (20) | -83.14 | Neutral |
| Williams %R (14) | -96.98 | Info |
| MACD (12,26,9) | -0.14 | Sell |
| ROC (12) | -10.46 | Sell |
| Bollinger %B (20,2) | 0.23 | Neutral |
| Stochastic %K (14) | 3.02 | Buy |
| TRIX (15) | -0.05 | Sell |
| Awesome (5,34) | -0.78 | Sell |
| Ultimate (7,14,28) | 23.58 | Buy |
| Momentum (10) | -1.93 | Sell |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 8.60 | Buy |
| ADX (14) | 12.54 | Neutral |
| ATR (14) | 0.30 | Info |
The 30-day technical picture shows bullish sentiment alongside a modest momentum. The RSI(14) is 40, and the stock sits above its 200-day average of $5.73 while trading near the 50-day average of $9.46. Support is at $8.60 and resistance at $10.66, framing a near-term range of $6.79 to $11.35 over the last 30 days.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.44 | $8.73 | $15.06 | 0% | Neutral | |
| $10.86 | $14.17 | $19.78 | +62% | Bullish | |
| $12.75 | $17.28 | $25.26 | +98% | Bullish | |
| $13.43 | $18.79 | $28.47 | +115% | Bullish | |
| $13.93 | $20.07 | $31.34 | +130% | Bullish | |
| $17.84 | $26.39 | $42.30 | +202% | Bullish | |
| $20.95 | $31.77 | $52.14 | +264% | Bullish | |
| $24.88 | $38.62 | $64.74 | +342% | Bullish | |
| $29.83 | $47.37 | $80.97 | +443% | Bullish | |
| $28.56 | $46.35 | $80.66 | +431% | Bullish | |
| $49.37 | $88.64 | $166.26 | +915% | Bullish | |
| $84.08 | $181.36 | $378.86 | +19.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.44 | $8.73 | $10.28 | +0.00% |
| June 2026 | $7.50 | $8.88 | $10.81 | +1.71% |
| July 2026 | $7.94 | $9.50 | $11.77 | +6.97% |
| August 2026 | $8.09 | $9.77 | $12.27 | +2.85% |
| September 2026 | $8.06 | $9.81 | $12.45 | +0.38% |
| October 2026 | $8.54 | $10.46 | $13.42 | +6.72% |
| November 2026 | $9.16 | $11.29 | $14.61 | +7.90% |
| December 2026 | $9.31 | $11.54 | $15.06 | +2.21% |
Click any year to see its month-by-month IMMX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The IMMX price prediction for 2026 points to an average of $8.73 (low $4.44, high $15.06) — a potential gain of 0% on today's $8.73. Price action looks broadly range-bound.
In 2027, IMMX is projected to trade between $10.86 and $19.78, averaging $14.17 — a potential gain of +62% from today's $8.73. That is up +62% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Immix Biopharma, Inc.'s 2028 outlook centres on $17.28, within a $12.75 to $25.26 range. That is up +22% on the projected 2027 average. That marks a +98% change versus current levels. Momentum favours further upside here.
By 2029, IMMX could reach as high as $28.47, with a base case around $18.79 and support toward $13.43 — roughly +115% from $8.73. Buyers look set to stay in control over this stretch.
Expect IMMX to range from $13.93 to $31.34 through 2030. The $20.07 average target implies a +130% move from current prices. That is up +7% on the projected 2029 average. Momentum favours further upside here.
The IMMX price prediction for 2031 points to an average of $26.39 (low $17.84, high $42.30) — a potential gain of +202% on today's $8.73. Buyers look set to stay in control over this stretch.
In 2032, IMMX is projected to trade between $20.95 and $52.14, averaging $31.77 — a potential gain of +264% from today's $8.73. That is up +20% on the projected 2031 average. Momentum favours further upside here.
Immix Biopharma, Inc.'s 2033 outlook centres on $38.62, within a $24.88 to $64.74 range. That is up +22% on the projected 2032 average. That marks a +342% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, IMMX could reach as high as $80.97, with a base case around $47.37 and support toward $29.83 — roughly +443% from $8.73. Momentum favours further upside here.
Expect IMMX to range from $28.56 to $80.66 through 2035. The $46.35 average target implies a +431% move from current prices. That is -2% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The IMMX price prediction for 2040 points to an average of $88.64 (low $49.37, high $166.26) — a potential gain of +915% on today's $8.73. Momentum favours further upside here.
In 2050, IMMX is projected to trade between $84.08 and $378.86, averaging $181.36 — a potential gain of +19.8x from today's $8.73. That is up +105% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in IMMX today (≈ 114.547537 IMMX) could be worth
$20,774.85
+$19,774.85 (+1977%) by 2050 · US Dollar
Based on the average projected IMMX price of $181.36 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IMMXwould be worth at today's price.
$1,000 invested in IMMX on May 27, 2025 (≈ 507.614206 IMMX) would be worth
$4,431.47
+$3,431.47 (+343.1%) today · 4.43× · US Dollar
Based on a IMMX entry price of $1.97 vs. today's $8.73.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.94 | $976.51 | -2.3% |
| 1 month ago | $9.53 | $916.05 | -8.4% |
| 3 months ago | $8.49 | $1,028.27 | +2.8% |
| 6 months ago | $4.25 | $2,054.12 | +105.4% |
| 1 year ago | $1.97 | $4,431.47 | +343.1% |
| All time (4.4y) ago | $3.67 | $2,378.75 | +137.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IMMX forecast.
Our base-case forecast reaches $17.00 around 2028.
Implied market cap at $17.00: $1.21B
The multi-year forecast points to substantial upside for Immix Biopharma. In 2026 the avg is $8.78 with a min of $4.44 and a max of $15.38 (ROI 0%), reflecting a neutral stance. From 2027 onward, the outlook shifts to bullish, with the avg rising to $14.42 in 2027, $17.42 in 2028, and $18.77 in 2029, and reaching $20.15 in 2030 (ROI 129.5%; sentiment BULLISH).
The forecast continues to show growth through 2050, with an avg of $180.30 and a max of $386.52 in 2050 (ROI 1953.5%; sentiment BULLISH). By 2031–2035 the averages climb to $26.46, $31.76, $39.05, $47.87 respectively, while the 2040 avg is $88.80 (ROI 911.4%) and the 2034–2035 windows reflect continued bullish momentum. These figures are estimates and carry uncertainty; actual results may differ.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $20.15, a min of $13.77, and a max of $31.95, with an ROI of 129.5% and sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages and ROIs up to 1953.5% by 2050; 2026 is neutral with an avg of $8.78.
Yes—the 2034 max is $83.39 and the 2040 max is $170.32, with the 2040 avg at $88.80, indicating the potential to exceed $50 by 2040.
Current price is $8.78 and market cap is $625.05M.
The 30-day range runs from $6.79 to $11.35.
Immix Biopharma, Inc. Community Discussion
0Share your Immix Biopharma, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.